0 Ratings
ID

14140

Description

Comparison of Liraglutide and Glimepiride on Blood Sugar Control in Subjects With Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT01509755

Link

https://clinicaltrials.gov/show/NCT01509755

Keywords

Versions (1)
  1. 3/31/16 3/31/16 -
Uploaded on

March 31, 2016

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

  • Newest
  • Oldest
  • Popular
  • Newest
    • Newest
    • Oldest
    • Popular

    No comments

    In order to download data models you must be logged in. Please log in or register for free.

    Eligibility Diabetes NCT01509755

    English

    Eligibility Diabetes NCT01509755

    1 forms  
    1. StudyEvent: Eligibility
      1. Eligibility Diabetes NCT01509755
    Inclusion Criteria
    Description

    Inclusion Criteria

    Alias
    UMLS CUI
    C1512693 (Inclusion)
    subjects with type 2 diabetes
    Description

    Type 2 Diabetes

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0011860 (Diabetes Mellitus, Non-Insulin-Dependent)
    SNOMED
    44054006
    duration of diabetes at least 3 months
    Description

    Duration of Diabtes

    Data type

    boolean

    Alias
    UMLS CUI [1,1]
    C0872146 (disease length)
    UMLS CUI [1,2]
    C0011860 (Diabetes Mellitus, Non-Insulin-Dependent)
    SNOMED
    44054006
    both diet treated and patients in therapy with oha (oral hypoglycemic agents)
    Description

    Diabetic diet and oral hypoglycemic agents

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0011878 (Diabetic Diet)
    SNOMED
    160670007
    UMLS CUI [2]
    C0359086 (oral hypoglycemics)
    body mass index maximum 40 kg/m^2
    Description

    Body mass index

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C1305855 (Body mass index)
    SNOMED
    60621009
    LOINC
    LP35925-4
    hba1c based on analysis from central laboratory: between 7.5-10.0%, both inclusive, for diet treated, or maximum 9.0% for oha treated
    Description

    Hba1c

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0019018 (Glycosylated hemoglobin A)
    LOINC
    LP16413-4
    Exclusion Criteria
    Description

    Exclusion Criteria

    Alias
    UMLS CUI
    C0680251 (Exclusion Criteria)
    liver or renal disease
    Description

    Liver or renal disease

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0023895 (Liver diseases)
    SNOMED
    235856003
    LOINC
    LA17774-3
    UMLS CUI [2]
    C0022658 (Kidney Diseases)
    SNOMED
    90708001
    cardiac problems
    Description

    Cardiac problems

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0262402 (cardiac problem)
    uncontrolled treated/untreated hypertension
    Description

    Hypertension

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0020538 (Hypertensive disease)
    SNOMED
    38341003
    LOINC
    MTHU020789
    proliferative retinopathy
    Description

    Proliferative retinopathy

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0339467 (Proliferative retinopathy)
    SNOMED
    430801000124103
    LOINC
    LA18648-8
    recurrent severe hypoglycaemia as judged by the investigator
    Description

    Recurrent severe hypoglycaemia

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0342316 (Recurrent severe hypoglycemia)
    SNOMED
    237636001
    known or suspected allergy to trial product or related products
    Description

    Allergy to trial product

    Data type

    boolean

    Alias
    UMLS CUI [1,1]
    C0020517 (Hypersensitivity)
    SNOMED
    421961002
    LOINC
    LP20697-6
    UMLS CUI [1,2]
    C3854006 (clinical trial drug)
    use of any drug (except for ohas) which in the investigator's opinion could interfere with the blood glucose level
    Description

    Pharmacotherapy interferes with blood glucose level

    Data type

    boolean

    Alias
    UMLS CUI [1,1]
    C0013216 (Pharmacotherapy)
    SNOMED
    416608005
    UMLS CUI [1,2]
    C0521102 (Interferes with)
    SNOMED
    78235001
    UMLS CUI [1,3]
    C0392201 (Blood glucose measurement)
    SNOMED
    33747003
    Back to the top of the page

    Similar models

    Eligibility Diabetes NCT01509755

    1 forms
    1. StudyEvent: Eligibility
      1. Eligibility Diabetes NCT01509755
    Name
    Type
    Description | Question | Decode (Coded Value)
    Data type
    Alias
    Item Group
    C1512693 (UMLS CUI)
    Type 2 Diabetes
    Item
    subjects with type 2 diabetes
    boolean
    C0011860 (UMLS CUI [1])
    Duration of Diabtes
    Item
    duration of diabetes at least 3 months
    boolean
    C0872146 (UMLS CUI [1,1])
    C0011860 (UMLS CUI [1,2])
    Diabetic diet and oral hypoglycemic agents
    Item
    both diet treated and patients in therapy with oha (oral hypoglycemic agents)
    boolean
    C0011878 (UMLS CUI [1])
    C0359086 (UMLS CUI [2])
    Body mass index
    Item
    body mass index maximum 40 kg/m^2
    boolean
    C1305855 (UMLS CUI [1])
    Hba1c
    Item
    hba1c based on analysis from central laboratory: between 7.5-10.0%, both inclusive, for diet treated, or maximum 9.0% for oha treated
    boolean
    C0019018 (UMLS CUI [1])
    Item Group
    C0680251 (UMLS CUI)
    Liver or renal disease
    Item
    liver or renal disease
    boolean
    C0023895 (UMLS CUI [1])
    C0022658 (UMLS CUI [2])
    Cardiac problems
    Item
    cardiac problems
    boolean
    C0262402 (UMLS CUI [1])
    Hypertension
    Item
    uncontrolled treated/untreated hypertension
    boolean
    C0020538 (UMLS CUI [1])
    Proliferative retinopathy
    Item
    proliferative retinopathy
    boolean
    C0339467 (UMLS CUI [1])
    Recurrent severe hypoglycaemia
    Item
    recurrent severe hypoglycaemia as judged by the investigator
    boolean
    C0342316 (UMLS CUI [1])
    Allergy to trial product
    Item
    known or suspected allergy to trial product or related products
    boolean
    C0020517 (UMLS CUI [1,1])
    C3854006 (UMLS CUI [1,2])
    Pharmacotherapy interferes with blood glucose level
    Item
    use of any drug (except for ohas) which in the investigator's opinion could interfere with the blood glucose level
    boolean
    C0013216 (UMLS CUI [1,1])
    C0521102 (UMLS CUI [1,2])
    C0392201 (UMLS CUI [1,3])
    Back to the top of the page 

    Help

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial